These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Five years experience of Clostridium difficile infection in children at a UK tertiary hospital: proposed criteria for diagnosis and management. Pai S; Aliyu SH; Enoch DA; Karas JA PLoS One; 2012; 7(12):e51728. PubMed ID: 23300561 [TBL] [Abstract][Full Text] [Related]
8. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity. Forster AJ; Daneman N; van Walraven C J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674 [TBL] [Abstract][Full Text] [Related]
9. Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe. Kurti Z; Lovasz BD; Mandel MD; Csima Z; Golovics PA; Csako BD; Mohas A; Gönczi L; Gecse KB; Kiss LS; Szathmari M; Lakatos PL World J Gastroenterol; 2015 Jun; 21(21):6728-35. PubMed ID: 26074711 [TBL] [Abstract][Full Text] [Related]
10. Risk Factors that Predict Recurrent Clostridium difficile Infections in Surgical Patients. Messick CA; Hammel JP; Hull T Am Surg; 2017 Jun; 83(6):653-659. PubMed ID: 28637570 [TBL] [Abstract][Full Text] [Related]
11. Clostridioides (Clostridium) difficile infection in Japanese hospitals 2008-2017: A real-world nationwide analysis of treatment pattern, incidence and testing density. Kimura T; Stanhope S; Sugitani T J Infect Chemother; 2020 May; 26(5):438-443. PubMed ID: 32081648 [TBL] [Abstract][Full Text] [Related]
12. Epidemiologic and Clinical Characteristics of Clostridioides difficile Infections in Hospitalized and Outpatient Pediatric Oncology and Hematopoietic Stem Cell Transplant Patients. Barbar R; Hayden R; Sun Y; Tang L; Hakim H Pediatr Infect Dis J; 2021 Jul; 40(7):655-662. PubMed ID: 34097657 [TBL] [Abstract][Full Text] [Related]
13. Treatment of first recurrence of Clostridium difficile infection: fidaxomicin versus vancomycin. Cornely OA; Miller MA; Louie TJ; Crook DW; Gorbach SL Clin Infect Dis; 2012 Aug; 55 Suppl 2(Suppl 2):S154-61. PubMed ID: 22752865 [TBL] [Abstract][Full Text] [Related]
15. Predictors of Clostridium difficile infection severity in patients hospitalised in medical intensive care. Khanafer N; Touré A; Chambrier C; Cour M; Reverdy ME; Argaud L; Vanhems P World J Gastroenterol; 2013 Nov; 19(44):8034-41. PubMed ID: 24307797 [TBL] [Abstract][Full Text] [Related]
16. Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection. Dieterle MG; Putler R; Perry DA; Menon A; Abernathy-Close L; Perlman NS; Penkevich A; Standke A; Keidan M; Vendrov KC; Bergin IL; Young VB; Rao K mBio; 2020 May; 11(3):. PubMed ID: 32371595 [No Abstract] [Full Text] [Related]
17. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil. Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474 [TBL] [Abstract][Full Text] [Related]
18. Time trends and predictors of laboratory-confirmed recurrent and severe Shaffer SR; Nugent Z; Walkty A; Yu BN; Lix LM; Targownik LE; Bernstein CN; Singh H CMAJ Open; 2020; 8(4):E737-E746. PubMed ID: 33199507 [TBL] [Abstract][Full Text] [Related]
19. Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden. Murphy CR; Avery TR; Dubberke ER; Huang SS Infect Control Hosp Epidemiol; 2012 Jan; 33(1):20-8. PubMed ID: 22173518 [TBL] [Abstract][Full Text] [Related]
20. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Dubberke ER; Butler AM; Yokoe DS; Mayer J; Hota B; Mangino JE; Khan YM; Popovich KJ; Fraser VJ Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1030-7. PubMed ID: 20695799 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]